These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 32640259)

  • 21. Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma.
    Huang L; Xu Y; Fang J; Liu W; Chen J; Liu Z; Xu Q
    Front Immunol; 2021; 12():654749. PubMed ID: 33936081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PI3Kα inhibitor CYH33 triggers antitumor immunity in murine breast cancer by activating CD8
    Sun P; Zhang X; Wang RJ; Ma QY; Xu L; Wang Y; Liao HP; Wang HL; Hu LD; Kong X; Ding J; Meng LH
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34373258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity.
    Kuehm LM; Wolf K; Zahour J; DiPaolo RJ; Teague RM
    Cancer Immunol Immunother; 2019 Jul; 68(7):1095-1106. PubMed ID: 31104075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Janus kinase inhibitor overcomes resistance to immune checkpoint inhibitor treatment in peritoneal dissemination of gastric cancer in C57BL/6 J mice.
    Du WY; Masuda H; Nagaoka K; Yasuda T; Kuge K; Seto Y; Kakimi K; Nomura S
    Gastric Cancer; 2024 Sep; 27(5):971-985. PubMed ID: 38805119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutual exclusivity and co-occurrence patterns of immune checkpoints indicate NKG2A relates to anti-PD-1 resistance in gastric cancer.
    Li G; Liu X; Gu C; Ma G; Li S; Ma Z; Xiong Y; Jiang Y; Huang Q; Wu J; Wu Z; Liao W; Wu Q; Shi M
    J Transl Med; 2024 Aug; 22(1):718. PubMed ID: 39097734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Programmed Death-1 Inhibition of Phosphatidylinositol 3-Kinase/AKT/Mechanistic Target of Rapamycin Signaling Impairs Sarcoidosis CD4
    Celada LJ; Rotsinger JE; Young A; Shaginurova G; Shelton D; Hawkins C; Drake WP
    Am J Respir Cell Mol Biol; 2017 Jan; 56(1):74-82. PubMed ID: 27564547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simvastatin induces ferroptosis and activates anti-tumor immunity to sensitize anti-PD-1 immunotherapy in microsatellite stable gastric cancer.
    Ning Y; Fang S; Zhang R; Fang J; Lin K; Ding Y; Nie H; Zhou J; Zhao Q; Ke H; Wang H; Wang F
    Int Immunopharmacol; 2024 Dec; 142(Pt B):113244. PubMed ID: 39317047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway.
    Huang YK; Kang WM; Ma ZQ; Liu YQ; Zhou L; Yu JC
    Carcinogenesis; 2019 Apr; 40(2):370-379. PubMed ID: 30371738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined cryoablation and PD-1 inhibitor synergistically enhance antitumor immune responses in Lewis lung adenocarcinoma mice via the PI3K/AKT/mTOR pathway.
    Liu Q; Chen X; Qi M; Li Y; Chen W; Zhang C; Wang J; Han Z; Zhang C
    Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167262. PubMed ID: 38815768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer.
    Zhu S; Ma AH; Zhu Z; Adib E; Rao T; Li N; Ni K; Chittepu VCSR; Prabhala R; Garisto Risco J; Kwiatkowski D; Mouw K; Sonpavde G; Cheng F; Pan CX
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34725212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Gu Y; Fei Z; Zhu R
    Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic Inhibition of FGFR Modulates the Metastatic Immune Microenvironment and Promotes Response to Immune Checkpoint Blockade.
    Akhand SS; Liu Z; Purdy SC; Abdullah A; Lin H; Cresswell GM; Ratliff TL; Wendt M
    Cancer Immunol Res; 2020 Dec; 8(12):1542-1553. PubMed ID: 33093218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8
    Tada Y; Togashi Y; Kotani D; Kuwata T; Sato E; Kawazoe A; Doi T; Wada H; Nishikawa H; Shitara K
    J Immunother Cancer; 2018 Oct; 6(1):106. PubMed ID: 30314524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway.
    Huang T; Liu D; Wang Y; Li P; Sun L; Xiong H; Dai Y; Zou M; Yuan X; Qiu H
    Cell Physiol Biochem; 2018; 50(4):1332-1345. PubMed ID: 30355943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
    Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
    Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas.
    Aslan K; Turco V; Blobner J; Sonner JK; Liuzzi AR; Núñez NG; De Feo D; Kickingereder P; Fischer M; Green E; Sadik A; Friedrich M; Sanghvi K; Kilian M; Cichon F; Wolf L; Jähne K; von Landenberg A; Bunse L; Sahm F; Schrimpf D; Meyer J; Alexander A; Brugnara G; Röth R; Pfleiderer K; Niesler B; von Deimling A; Opitz C; Breckwoldt MO; Heiland S; Bendszus M; Wick W; Becher B; Platten M
    Nat Commun; 2020 Feb; 11(1):931. PubMed ID: 32071302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of "regulation of RhoA activity panel" as a prognostic and predictive biomarker for gastric cancer.
    Huang W; Zhao S; Zhang C; Li Z; Ge S; Lian B; Feng H; Wang K; Xu R; Ji J; Gao J; Shi W; Shen L
    Aging (Albany NY); 2020 Dec; 13(1):714-734. PubMed ID: 33288739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatty Acid Oxidation Controls CD8
    Lin R; Zhang H; Yuan Y; He Q; Zhou J; Li S; Sun Y; Li DY; Qiu HB; Wang W; Zhuang Z; Chen B; Huang Y; Liu C; Wang Y; Cai S; Ke Z; He W
    Cancer Immunol Res; 2020 Apr; 8(4):479-492. PubMed ID: 32075801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin analog GO-Y030 boosts the efficacy of anti-PD-1 cancer immunotherapy.
    MaruYama T; Kobayashi S; Shibata H; Chen W; Owada Y
    Cancer Sci; 2021 Dec; 112(12):4844-4852. PubMed ID: 34529884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.